Abstract
Idiosyncratic drug reactions represent a poorly understood problem with serious medical implications. Many idiosyncratic drug reactions appear to be hypersensitivity reactions that involve an immune mechanism. The initiating step appears to involve the formation of a chemically reactive metabolite which can act as a hapten. Although the major site of drug metabolism is the liver, we have found that leukocytes, which contain myeloperoxidase and can generate hydrogen peroxide when stimulated, can also generate reactive metabolites. This has obvious implications for such idiosyncratic reactions as agranulocytosis. Furthermore, because of the importance of monocytes in the processing of antigen and the presentation of antigen to T lymphocytes in the initiation of an immunological reaction, formation of reactive metabolites by monocytes may also have implications for other idiosyncratic reactions such as drug-induced lupus and generalized idiosyncratic reactions.
Similar content being viewed by others
REFERENCES
C. W. Parker. Pharmacol. Rev. 34:85–104 (1982).
E.-S. K. Assem. In D. M. Davies (ed.), Textbook of Adverse Drug Reactions, Oxford University Press, New York, 1985, pp. 613–633.
B. K. Park, J. W. Coleman, and N. R. Kitteringham. Biochem. Pharmacol. 36:581–590 (1987).
L. R. Pohl, H. Satoh, D. D. Christ, and J. G. Kenna. Annu. Rev. Pharmacol. 28:367–387 (1988).
J. Uetrecht, N. Zahid, N. H. Shear, and W. D. Biggar. J. Pharmacol. Exp. Ther. 245:274–279 (1988).
J. Uetrecht, N. Zahid, and R. Rubin. Chem. Res. Toxicol. 1:74–78 (1988).
J. Uetrecht and N. Zahid. Chem. Res. Toxicol. 1:148–151 (1988).
J. P. Uetrecht. Chem. Res. Toxicol. 1:133–143 (1988).
L. Waldhauser and J. Uetrecht. FASEB J. 2:A1134 (1988).
G. E. McLain, I. G. Sipes, and B. R. Brown. Anesthesiology 51:321–326 (1979).
J. L. Plummer, A. L. Beckwith, F. N. Bastin, J. F. Adams, M. J. Cousins, and P. Hall. Anesthesiology 57:160–166 (1982).
J. Uetrecht, A. J. Wood, J. M. Phythyon, and M. Wood. Anesthesiology 59:196–201 (1983).
D. Vergani, G. Mieli Vergani, A. Alberti, J. Neuberger, A. Eddleston, M. Davis, and R. Williams. N. Engl. J. Med. 303:66–71 (1980).
J. M. Neuberger, G. Mieli Vergani, J. M. Tredger, M. Davis, and R. Williams. Gut 22:669–672 (1981).
J. G. Kenna, H. Satoh, D. D. Christ, and L. R. Pohl. J. Pharmacol. Exp. Ther. 245:1103–1109 (1988).
Ph. Beaune, P. M. Dansette, D. Mansuy, L. Kiffel, M. Finck, C. Amar, J. P. Leroux, and J. C. Homberg. Proc. Natl. Acad. Sci. USA 84:551–555 (1987).
M. Black, J. R. Mitchell, H. J. Zimmerman, K. Ishak, and G. R. Epler. Gastroenterology 69:289–302 (1975).
J. A. Timbrell, J. R. Mitchell, W. R. Snodgrass, and S. D. Nelson. J. Pharmacol. Exp. Ther. 213:364–369 (1980).
S. Asai, T. Shimoda, K. Hara, and K. Fujiwara. J. Allergy Clin. Immunol. 80:578–585 (1987).
H. J. Zimmerman. Drugs 16:25–45 (1978).
S. D. Nelson, J. R. Mitchell, W. R. Snodgrass, and J. A. Timbrell. J. Pharmacol. Exp. Ther. 206:574–585 (1978).
N. G. Powers and S. H. Carson. Clin. Pediat. 26:120–124 (1987).
G. A. B. Davies-Jones. In M. N. G. Dukes (ed.), Meyler's Side Effects of Drugs, Elsevier, Amsterdam, 1984, pp. 109–119.
H. J. Zimmerman and K. G. Ishak. Hepatology 2:591–597 (1982).
R. L. Woosley, D. E. Drayer, M. M. Reidenberg, A. S. Nies, K. Carr, and J. A. Oates. N. Engl. J. Med. 298:1157–1159 (1978).
D. J. Wallace and E. L. Dubois (eds.), Dubois' Lupus Erythematosus, Lea & Febiger, Philadelphia, 1987.
M. J. Fritzler and E. M. Tan. J. Clin. Invest. 62:560–567 (1978).
R. L. Rubin, G. Reimer, E. M. McNally, S. R. Nusinow, R. P. Searles, and E. M. Tan. Clin. Exp. Immunol. 63:58–67 (1986).
J. P. Uetrecht, B. J. Sweetman, R. L. Woosley, and J. A. Oates. Drug Metab. Dispos. 12:77–81 (1984).
J. P. Uetrecht. J. Pharmacol. Exp. Ther. 232:420–425 (1985).
R. L. Rubin, J. P. Uetrecht, and J. E. Jones. J. Pharmacol. Exp. Ther. 242:833–841 (1987).
E. R. Unanue and P. M. Allen. Science 236:551–557 (1987).
J. P. Uetrecht, N. Shear, and W. Biggar. Pharmacologist 28:239 (1986).
E. B. Raftery and A. M. Denman. Br. Med. J. 2:452–455 (1973).
R. J. Booth, J. Y. Bullock, and J. D. Wilson. Br. J. Clin. Pharmacol. 9:515–517 (1980).
R. J. Booth, J. D. Wilson, and J. Y. Bullock. Clin. Pharmacol. Ther. 31:555–558 (1982).
H. M. Perry, Jr. Am. J. Med. 54:58–72 (1973).
A. Hofstra and J. P. Uetrecht. Pharmacologist 30:A99 (1988).
J. A. Timbrell, V. Facchini, S. J. Harland, and R. Mansilla-Tinoco. Eur. J. Clin. Pharmacol. 27:555–559 (1984).
A. Li and J. P. Uetrecht. Pharmacologist 30:A99 (1988).
J. A. Amrhein, F. M. Kenny, and D. Ross. J. Pediat. 76:54–63 (1970).
D. P. Aucoin, M. E. Peterson, A. I. Hurvitz, D. E. Drayer, R. G. Lahita, F. W. Quimby, and M. M. Reidenberg. J. Pharmacol. Exp. Ther. 234:13–18 (1985).
B. H. Singsen, L. Fishman, and V. Hanson. Pediatrics 57:529–534 (1976).
C. Martz, C. Failinger, and D. A. Blake. J. Pharmacol. Exp. Ther. 203:231–239 (1977).
B. E. Berger and D. J. Hauser. Am. Heart J. 105:1035–1036 (1983).
J. Nelson, J. Lutton, and A. Fass. Am. J. Hematol. 17:427–432 (1984).
A. G. Ellrodt, G. H. Murata, M. S. Riedinger, M. E. Stewart, C. Mochizuki, and R. Gray. Ann. Intern. Med. 100:197–201 (1984).
J. Azocar. Lancet 1:1069–1070 (1984).
W. McKenna and A. Chalmers. Br. Med. J. 1:324–325 (1958).
A. Ognibene. Ann. Intern. Med. 72:521–524 (1970).
F. Firkin and A. Mariani. Med. J. Aust. 2:247–251 (1977).
R. M. Weetman, L. A. Boxer, M. P. Brown, N. M. Mantich, and R. L. Baehner. Br. J. Haematol. 45:361–370 (1980).
S. S. Rinkoff and M. Spring. Ann. Intern. Med. 15:89–91 (1941).
H. Engler, A. Taurog, and T. Nakashima. Biochem. Pharmacol. 31:3801–3806 (1982).
R. Bouillon. In M. N. G. Dukes (ed.), Meyler's Side Effects of Drugs, Elsevier, Asterdam, 1984, p. 786.
M. M. Guffy, N. E. Goeken, and P. C. Burns. Arch. Intern. Med. 144:1687–1688 (1984).
E. F. Fibbe, F. H. Claas, W. Van der Star-Dijkstra, M. R. Schaafsma, R. H. Meyboom, and J. H. Frederik. Br. J. Haematol. 64:363–373 (1986).
R. Scheline. Pharmacol. Rev. 25:451–523 (1975).
D. R. Manyan, G. K. Arimura, and A. A. Yunis. Mol. Pharmacol. 11:520–527 (1975).
M. Ascherl, P. Eyer, and H. Kampffmeyer. Biochem. Pharmacol. 34:3755–3763 (1985).
A. A. Yunis, A. M. Miller, Z. Salem, M. D. Corbett, and G. K. Arimura. J. Lab. Clin. Med. 96:36–46 (1980).
B. J. Gross, R. V. Branchflower, T. R. Burke, D. E. Lees, and L. R. Pohl. Toxicol. Appl. Pharmacol. 64:557–565 (1982).
J. J. Jimenez, M. Isildar, and A. A. Yunis. Blood 70:1180–1185 (1987).
T. W. Rall and L. S. Schleifer. In A. G. Gilman, L. S. Goodman, T. W. Rall, and F. Murad (eds.). Goodman and Gillman's The Pharmacological Basis of Therapeutics, MacMillan, New York, 1985, pp. 446–472.
W. H. Inman. Br. Med. J. 1:1500–1505 (1977).
S. Ichihara, H. Tomisawa, H. Fukazawa, M. Tateishi, R. Joly, and R. Heintz. Biochem. Pharmacol. 35:3935–3939 (1986).
V. Pisciotta. Drugs 15:132–143 (1978).
D. Kadar and W. Kalow. Clin. Pharmacol. Ther. 28:820–822 (1980).
S. M. Worlledge, K. C. Carstairs, and J. V. Dacie. Lancet 2:135–139 (1966).
A. Gupta, L. Waldhauser, M. Reider, P. Harper, D. Daneman, M. Eggo, N. Shear, J. Uetrecht, and S. Spielberg. Pediat. Res. 23:277A (1988).
G. L. Mandell and M. A. Sande. In A. G. Gilman, L. S. Goodman, T. W. Rall, and F. Murad (eds.), Goodman and Gillman's The Pharmacological Basis of Therapeutics, Macmillan, New York, 1985, pp. 1101–1102.
H. Jick. Rev. Infect. Dis. 4:426–428 (1982).
M. J. Rieder, J. Uetrecht, N. H. Shear, and S. P. Spielberg. J. Pharmacol. Exp. Ther. 244:724–728 (1988).
M. J. Rieder, J. Uetrecht, N. Shear, M. Cannon, M. Miller, and S. P. Spielberg. Ann. Intern. Med. (in press).
M. Brown and T. Schubert. J. Clin. Gastroenterol. 8:469–477 (1986).
J. S. Aaron, S. Bank, and G. Ackert. Am. J. Gastroenterol. 80:200–202 (1985).
R. P. Abratt, R. Sealy, C. J. Uys, and R. Lawson. Clin. Oncol. 8:351–356 (1982).
T. C. Sorrell, I. J. Forbes, F. R. Burness, and R. H. Rischbieth. Lancet 2:1233–1235 (1971).
N. E. Gilhus, R. Matre, and J. A. Aarli. Int. J. Immunopharm. 4:43–48 (1982).
G. Ricevuti, M. Marcoli, G. Gatti, A. Mazzone, S. Lecchini, and G. M. Frigo. Hum. Toxicol. 5:237–241 (1986).
I. C. Guerra, W. A. Fawcett, A. H. Redmon, E. C. Lawrence, H. M. Rosenblatt, and W. T. Shearer. J. Allergy Clin. Immunol. 77:603–607 (1986).
C. J. Rosenthal, C. A. Noguera, A. Coppola, and S. N. Kapelner. Cancer 49:2305–2314 (1982).
S. P. Spielberg, G. B. Gordon, D. A. Blake, D. A. Goldstein, and H. F. Herlong. N. Engl. J. Med. 305:722–727 (1981).
S. J. Grossman and D. J. Jollow. J. Pharmacol. Exp. Ther. 244:118–125 (1988).
J. R. Wilson and J. W. Harris. Ohio State Med. J. 73:557–560 (1977).
H. M. Frey, A. A. Gershon, W. Borkowsky, and W. E. Bullock. Ann. Intern. Med. 94:777–779 (1981).
N. P. Kromann, R. Vilhelmsen, and D. Stahl. Arch. Dermatol. 118:531 (1982).
P. K. Das, P. R. Klatser, K. W. Pondman, H. Huikeshoven, J. E. Landheer, D. L. Leiker, and R. J. Rees. Lancet 1:1309–1310 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Uetrecht, J.P. Idiosyncratic Drug Reactions: Possible Role of Reactive Metabolites Generated by Leukocytes. Pharm Res 6, 265–273 (1989). https://doi.org/10.1023/A:1015934104984
Issue Date:
DOI: https://doi.org/10.1023/A:1015934104984